Profitelligence Profitelligence · Filing Ledger Open TEM research →

Form 8-K · Current Report · Filed 2024-11-04

Tempus AI Reports Q3 2024 Results and Ambry Genetics Acquisition

Tempus AI, Inc. reported a 33.0% year-over-year increase in revenue for the third quarter of 2024, reaching $180.9 million. The company also announced an agreement to acquire Ambry Genetics, a leader in genetic testing, for $375 million in cash and $225 million in shares. The acquisition is expected to enhance Tempus's hereditary cancer screening capabilities and expand its disease coverage. Additionally, Tempus provided financial guidance for the full year 2024, expecting revenue of approximately $700 million and an adjusted EBITDA of approximately ($105 million).

Filer
Tempus AI Inc. TEM · NASDAQ
Filed
Accession
0000950170-24-120663
CIK
0001717115
Signal
Low impactHealthcare

Items reported

Item 2.02

Results of Operations and Financial Condition

General Statement
Item 7.01

Regulation FD Disclosure

Regulation FD Disclosure
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$46.06

Next session

-3.4%

Since filing

-4.8%

Latest close

$43.87

What happened, not what will happen — closing prices around the filing date.

Exhibits (1)

About Tempus AI Inc.

Tempus AI Inc. is a pioneering technology company specializing in the development and application of artificial intelligence solutions across various industries. Its primary function is to harness AI-driven insights to enhance operational efficiency and decision-making processes for enterprises. Tempus AI Inc. is at the forefront of integrating machine learning into sectors such as healthcare, finance, and logistics, where predictive data analytics can provide substantial competitive advantages. The company delivers bespoke AI platforms that enable organizations to streamline complex data sets into actionable intelligence. Its expertise extends to natural language processing and computer vision, offering comprehensive AI tools that drive innovation and efficiency. As a significant player in the tech market, Tempus AI Inc. contributes to setting industry standards for AI deployment, impacting how businesses leverage intelligent technology to improve outcomes and strategic planning. Founded with a mission to propel the development of intelligent systems, Tempus AI Inc. remains a vital contributor to the digital transformation of multiple industries, facilitating the transition towards a more data-driven future.

Exchange NASDAQ Industry Health Information Services Company website ↗

Never miss another TEM filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts